ConductScience.org, home

Paper4587653

Proceedings: The effect of immunosuppression on cancer.

Penn I and 1 other. Proc Natl Cancer Conf, 1972. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Proceedings: The effect of immunosuppression on cancer. Papers, record 4587653. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4587653

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Proceedings: The effect of immunosuppression on cancer.
PubMed
Journal
Proc Natl Cancer Conf
PubMed
Year
1972
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.29
iCite
Revised in PubMed
2024-05-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Penn II
2Starzl TET E

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarcinogensMajor topic
Immunosuppression TherapyMajor topic
Immunosuppressive AgentsMajor topic
NeoplasmsMajor topic
Antineoplastic Agents
Arthritis, Rheumatoid
Follow-Up Studies
Humans
Kidney Transplantation
Neoplasm Transplantation
Nephrotic Syndrome
Psoriasis
Transplantation, Homologous

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
M01 RR000051NCRR NIH HHSUnited StatesM01RR000051PubMedNIH RePORTER
M01 RR000069NCRR NIH HHSUnited StatesM01RR000069PubMedNIH RePORTER
R01 AM007772NIDDK NIH HHSUnited StatesR01AM007772PubMedNIH RePORTER
R01 AM007772NIADDK NIH HHSUnited StatesR01AM007772PubMedNIH RePORTER

Download CSV of grants

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114492019Renal lesions associated with malignant lymphomas.Am J Med1962https://conductscience.org/library/papers/14492019PubMed
25280477Monocytic and monomyelocytic leukaemia with increased serum and urine lysozyme as a late complication in plasma cell myeloma.Br Med J1971https://conductscience.org/library/papers/5280477PubMed
35853249Chromosomal abnormalities produced by folic acid antagonists.Br J Dermatol1965https://conductscience.org/library/papers/5853249PubMed
44301103Interstitial pulmonary fibrosis, atypical epithelial changes and bronchiolar cell carcinoma following busulfan therapy.Cancer1968https://conductscience.org/library/papers/4301103PubMed
54113402Leukaemic transformation of engrafted human marrow cells in vivo.Lancet1972https://conductscience.org/library/papers/4113402PubMed
64100352Myelomonocytic leukaemia supervening on chronic lymphocytic leukaemia.Lancet1971https://conductscience.org/library/papers/4100352PubMed
85288349Leukaemia on myeloma.Br Med J1971https://conductscience.org/library/papers/5288349PubMed
95580290Malignancy during methotrexate and steroid therapy for psoriasis.Arch Dermatol1971https://conductscience.org/library/papers/5580290PubMed
104621360Acute leukemia following cytotoxic chemotherapy.JAMA1972https://conductscience.org/library/papers/4621360PubMed
114113171Multiple myeloma--intermittent combination chemotherapy compared to continuous therapy.Cancer1972https://conductscience.org/library/papers/4113171PubMed
125580291Methotrexate-induced carcinoma?Arch Dermatol1971https://conductscience.org/library/papers/5580291PubMed
135283781Cyclophosphamide and the bladder.Br Med J1971https://conductscience.org/library/papers/5283781PubMed
146059136Chromosome studies in patients treated with azathioprine and amethopterin.Acta Med Scand1967https://conductscience.org/library/papers/6059136PubMed
1513951337Cytologic dysplasia related to busulfan (Myleran) therapy. Report of a case.Obstet Gynecol1963https://conductscience.org/library/papers/13951337PubMed
1614201279CARCINOGENIC ACTIVITY OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213).Cancer Chemother Rep1964https://conductscience.org/library/papers/14201279PubMed
176034956Extraosseous lesions in plasma cell myeloma. A report of six cases.Am J Med1967https://conductscience.org/library/papers/6034956PubMed
185171831Reticulosis as a long-term side-effect of methotrexate therapy in a patient with generalized psoriasis and psoriatic arthritis.Dermatologica1971https://conductscience.org/library/papers/5171831PubMed
195337286Symposium on immunosuppressive drugs. Late effects of immunosuppressive anticancer drugs.Fed Proc1967https://conductscience.org/library/papers/5337286PubMed
205554838Azathioprine treatment of ulcerative colitis, granulomatous colitis and regional enteritis.Am J Dig Dis1971https://conductscience.org/library/papers/5554838PubMed
215286447Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis.Cancer1971https://conductscience.org/library/papers/5286447PubMed

See all 68 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
36675037Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers.Int J Mol Sci2023https://conductscience.org/library/papers/36675037PubMed
32488850Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.Cell Oncol (Dordr)2020https://conductscience.org/library/papers/32488850PubMed
29483997Sarcoidosis in A. C. Milan (1899)?Open Access Maced J Med Sci2018https://conductscience.org/library/papers/29483997PubMed
29285261Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer.Oncotarget2017https://conductscience.org/library/papers/29285261PubMed
28582845Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments.Cancer Biomark2017https://conductscience.org/library/papers/28582845PubMed
17521218Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.Drugs2007https://conductscience.org/library/papers/17521218PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4587653

GET https://conductscience.org/api/papers/v1/4587653/references?page=2